Apple and Google join forces for COVID-19 contact tracing

Technology companies Apple and Google have teamed up to build an element of contact tracing to aid in the COVID-19 response. Its new technology, Exposure Notifications, enables public health agencies to create apps using the two companies’ API.

Contact tracing is an important part of the COVID-19 response, as people can be warned when they’ve come into contact with someone who may have been infected by the virus and public health officials can trace the progression of the disease. Google and Apple previously announced last month they were working on a way to alert user when they were in contact with someone who was COVID-19 positive.

“Starting today, our Exposure Notifications technology is available to public health agencies on both iOS and Android,” a joint statement from the companies reads. “What we’ve built is not an app—rather public health agencies will incorporate the API into their own apps that people install. Our technology is designed to make these apps work better.”

Users decide whether to opt into Exposure Notifications and the system does not collect or use location from the device. It is also up to a person if they are diagnosed with COVID-19 whether or not to report their diagnosis in the public health app.

“Today, this technology is in the hands of public health agencies across the world who will take the lead and we will continue to support their efforts,” the statement concludes.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.